• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Research

Independent equity research and analysis from our analyst team

Research

Independent equity research and analysis from our analyst team

Digital Workforce: Acquisition well aligned with strategy
Research02.07.2026 klo 09.15 by
Joni Grönqvist

Digital Workforce: Acquisition well aligned with strategy

Digital Workforce announced yesterday that it has acquired AI agent capabilities, which aligns well with the company's strategy.

Digital Workforce
Flügger Q4'25/26: Top-line growth offsets softer margins while the structural case holds
Research30.06.2026 klo 08.00 by
Rasmus Køjborg, Victor Skriver

Flügger Q4'25/26: Top-line growth offsets softer margins while the structural case holds

Flügger closed 2025/26 with revenue of MDKK 2,313 (+2% y/y), marginally above our MDKK 2,298 estimate, and EBIT of MDKK 108 (+15%), both within guidance. Reported EBIT met our forecast, though earnings quality was a touch softer, with EBITDA, PTP and EPS landing a few percent below as admin and ERP costs ran ahead of our modelling. Poland again led growth at +11% local currency for the full year, while the Nordic segment rose 2% as the planned private-label phase-out masked improving core demand from professional painters and consumers. The new 2026/27 guidance of MDKK 2,400-2,500 revenue and MDKK 105-125 EBIT lifts our revenue outlook but trims our EBIT trajectory, the main change to our estimates for 2026/27e. We reiterate our "Accumulate" recommendation, with the ongoing sanctions case remaining the key risk factor, and raise our target price to DKK 410 per share (prev. DKK 360).

Flügger Group
Spinnova: Strategy on track, but risk/reward remains murky
Research30.06.2026 klo 08.51 by
Antti Viljakainen, Kaisa Vanha-Perttula

Spinnova: Strategy on track, but risk/reward remains murky

We have not made any material changes to our forecasts, even though Spinnova appears to have advanced its strategy both in terms of assembling a cooperation consortium around the technology and verifying the reduction in the technology's production and investment costs.

Spinnova

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Biohit: Sold on summer sale
Research29.06.2026 klo 09.00 by
Antti Siltanen

Biohit: Sold on summer sale

The stock's valuation has fallen to a rather low level.

Biohit
H&M Q2'26: Profitability holds, top line still searching for traction
Research26.06.2026 klo 07.00 by
Lucas Mattsson

H&M Q2'26: Profitability holds, top line still searching for traction

In our view, H&M's Q2 report confirmed that the overall story remains unchanged: weak top-line momentum, but improved profitability driven by internal efficiency measures and external margin tailwinds.

H&M
Eltel: The easy money is made
Research25.06.2026 klo 08.30 by
Christoffer Jennel

Eltel: The easy money is made

Following the strong post-Q1 share price surge, however, we believe the valuation has run too far, and the risk-adjusted return is no longer attractive at current levels.

Eltel
Bioretec Extensive Report: Signs of recovery in growth fracture
Extensive research25.06.2026 klo 14.13 by
Antti Siltanen

Bioretec Extensive Report: Signs of recovery in growth fracture

We expect the company to show clear signs of growth this year.

Bioretec
Roblon (Investment case): Cyclical trough, new GPS-3 strategy and repositioning towards critical energy infrastructure in focus
Research24.06.2026 klo 09.30 by
Rasmus Køjborg, William Jørck

Roblon (Investment case): Cyclical trough, new GPS-3 strategy and repositioning towards critical energy infrastructure in focus

Following Roblon's H1 2025/26 interim report, we have updated our investment case on the company. Our updated investment case covers the key investment reasons, risks, and valuation perspective relative to fibre and composite peers.

Roblon
Fiskars Extensive Report: Vita's turnaround is already baked into the price
Extensive research24.06.2026 klo 12.33 by
Rauli Juva

Fiskars Extensive Report: Vita's turnaround is already baked into the price

Fiskars is currently a brand house divided into two independent segments (Fiskars and Vita).

Fiskars
Apetit: Valuation cooled down a notch
Research22.06.2026 klo 21.34 by
Kaisa Vanha-Perttula, Pauli Lohi

Apetit: Valuation cooled down a notch

The valuation of the stock has moderated due to the share price decline, but cost pressures limit the visibility of an earnings turnaround.

Apetit
Alexandria Extensive Report: The strategy is taking the company in the right direction
Extensive research22.06.2026 klo 10.24 by
Sauli Vilén

Alexandria Extensive Report: The strategy is taking the company in the right direction

Alexandria's valuation is cheap, and the potential success of asset management offers a potential bonus.

Alexandria Group
Solwers: Covenant knot tightens as earnings development falters
Research18.06.2026 klo 10.08 by
Olli Vilppo

Solwers: Covenant knot tightens as earnings development falters

Solwers withdrew its guidance yesterday, suggesting that a critical earnings improvement may not materialize this year. We lowered our estimates.

Solwers
Talenom extensive report: Finland stands firm, international turnaround is key
Extensive research18.06.2026 klo 17.39 by
Juha Kinnunen

Talenom extensive report: Finland stands firm, international turnaround is key

Talenom's Finnish core business continues to reliably generate strong cash flow, but investors doubt the sensibility of international growth.

Talenom
H&M Q2'26 preview: Soft topline, but margins resilient so far
Research17.06.2026 klo 07.30 by
Lucas Mattsson

H&M Q2'26 preview: Soft topline, but margins resilient so far

We believe revenue growth remained soft in H&M's Q2, driven by weak market data, reflecting softer consumer confidence and cold weather in April.

H&M
Oriola Extensive Report: Patience prescribed
Extensive research23.06.2026 klo 12.15 by
Rauli Juva

Oriola Extensive Report: Patience prescribed

Oriola's stock looks cheap, but there are clear risks associated with both the balance sheet and operational activities.

Oriola
Kreate: Strong outlook materializes into growth
Research17.06.2026 klo 09.20 by
Atte Jortikka

Kreate: Strong outlook materializes into growth

We find the pricing still seems reasonable, considering our significantly raised earnings estimates and the expectation of substantial earnings growth.

Kreate Group
Scanfil extensive report: Good quality with full short-term pricing
Extensive research17.06.2026 klo 18.52 by
Antti Viljakainen

Scanfil extensive report: Good quality with full short-term pricing

We raise our target price for Scanfil to EUR 12.50 (was 11.50 €) on the heels of slightly increased long-term growth estimates. Following the robust progress of the share price over the past year, the positive earnings growth projected in our forecasts has already been factored into the share. In our view, this narrows Scanfil's short-term expected return, even though the long-term story remains quite attractive.

Scanfil
Nightingale: We factored the project delay into our estimates
Research12.06.2026 klo 10.20 by
Antti Siltanen, Antti Luiro

Nightingale: We factored the project delay into our estimates

The revenue outlook for the next fiscal year exceeds 10 MEUR.

Nightingale Health
Puuilo Q1'26: Spot on
Research12.06.2026 klo 09.09 by
Arttu Heikura

Puuilo Q1'26: Spot on

Virtually all of the company's key metrics developed in a more positive direction.

Puuilo
Suominen: Share issue in figures, valuation still high
Research11.06.2026 klo 09.12 by
Rauli Juva

Suominen: Share issue in figures, valuation still high

We updated the impact of the share issue on our estimates, but operationally our assumptions remained unchanged.

Suominen